| GeneLibs

题目:: Lung cancer prediction
ID:
状态:: 发布时间Feb. 28, 2010 , 更新时间 May 1, 2014 , 提交时间 Sept. 12, 2008,
物种:: Homo sapiens
摘要:: We generated a blood-derived transcriptional signature that discriminates patients with lung cancer from non-affected smokers. When applied to blood samples from one of the largest prospective population-based cancer studies (the European Prospective Investigation into Cancer and Nutrition), this signature accurately predicted the occurrence of lung cancer in smokers within two years before the onset of clinical symptoms. Such a blood test could be used as a screening tool to enable early diagnosis of lung cancer at a curable stage. All samples were taken from smokers. EPIC cases were taken from the EPIC trial (a large prospective epidemiological trial in Europe, and are incident cases), Cosmos and BC cases are prevalent cases from a Cologne, Germany based epidemiological trial.
实验种类:: transcription profiling by array
样本量:: 292
实验设计:
: 无设计数据
数据号:: E-GEOD-12771, GSE12771
数据状态:: 无法自动分析，您可以尝试手动分析数据。

实验库数据相关信息